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SUMMARY
Reprogramming of ﬁbroblasts to induced pluripotent stem cells (iPSCs) entails a mesenchymal to epithelial transition (MET). While
attempting to dissect the mechanism of MET during reprogramming, we observed that knockdown (KD) of the epithelial-to-mesen-
chymal transition (EMT) factor SNAI1 (SNAIL) paradoxically reduced, while overexpression enhanced, reprogramming efﬁciency in
humancellsandin mousecells, dependingon strain.We observed nuclear localization of SNAI1at an early stageof ﬁbroblastreprogram-
ming and using mouse ﬁbroblasts expressing a knockin SNAI1-YFP reporter found cells expressing SNAI1 reprogrammed at higher efﬁ-
ciency. We further demonstrated that SNAI1 binds the let-7 promoter, which may play a role in reduced expression of let-7 microRNAs,
enforced expression of which, early in the reprogramming process, compromises efﬁciency. Our data reveal an unexpected role for the
EMT factor SNAI1 in reprogramming somatic cells to pluripotency.
INTRODUCTION
Reprogramming somatic cells to induced pluripotent stem
cells (iPSCs) holds great promise for disease modeling and
therapeutic applications. Among the challenges that
remain is the extended time frame and variable efﬁciency
of transcription factor-based reprogramming; in most
cases, fewer than 0.05% of the target population will
form bona ﬁde iPSC colonies (Chan et al., 2009; Takahashi
et al., 2007). Improving our knowledge of the mecha-
nisms of reprogramming should facilitate more efﬁcient
reprogramming.
Studies aimed at elucidating the mechanism of reprog-
ramming somatic cells to pluripotency have revealed a
multistep process in which exogenous OCT4, SOX2,
KLF4, and MYC (OSKM) expression initiates events result-
inginendogenous expression ofpluripotency factorsanda
stable iPSC phenotype. Fibroblasts, the somatic cells most
often targeted for reprogramming, are quintessential
mesenchymal cells, whereas embryonic stem (ES) or iPSCs
express epithelial markers. Completion of the prolonged
reprogramming process entails upregulation of epithelial
factors and downregulation of mesenchymal factors—a
classic mesenchymal to epithelial transition (MET) (Sama-
varchi-Tehrani et al., 2010). KLF4 has been shown to
induce E-cadherin and other epithelial factors, whereas
SOX2 and OCT4 downregulate SNAI1 (Li et al., 2010).
Thus, a mechanistic link between MET and ﬁbroblast re-
programming has been proposed.
However, considerable data suggest that reprogramming
is not a simple MET from start to ﬁnish. A sequential appli-
cation of reprogramming factors, shown to induce an early
epithelial-to-mesenchymaltransition(EMT),improvesefﬁ-
ciency, as does early transforming growth factor-b (TGF-b)
treatment or Slug expression (Liu et al., 2013). Wnt
signaling, which promotes EMT, enhances reprogramming
if activated early inthe process (Marson et al.,2008). Inhib-
itors of TGF-b signaling, which promote MET, can enhance
reprogramming if administered concomitant with OSKM
expression (Ichida et al., 2009) but antagonize reprogram-
ming if administered in the 3 preceding days (Maherali
and Hochedlinger, 2009). Taken together, these data imply
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role in the reprogramming process. The role of EMT factors
in induction of pluripotency has not been extensively
explored.
The transcription factor SNAI1 represses epithelial fac-
tors such as E-cadherin, and its expression is sufﬁcient for
EMT (Cano et al., 2000). It exerts a positive inﬂuence on
the expression of stemness factors, including SOX2 and
KLF4, via effects on microRNAs (miRs) (Garibaldi et al.,
2012), and has been shown to decrease proliferation while
preventing apoptosis (Vega et al., 2004).
LIN28, a regulator of miR biogenesis and an alternative
reprogramming factor (Viswanathan et al., 2008; Yu
et al., 2007), inhibits the processing and maturation of
let-7 and is in turn a let-7 target (Rybak et al., 2008).
Mature let-7 family miRs, regulators of developmental
timing (Ambros, 2011), are absent in pluripotent cells
and are expressed at high levels in differentiated cell pop-
ulations (Viswanathan et al., 2008). Let-7 inhibits expres-
sion of pluripotency factors (including LIN28, c-MYC,
and SALL4) (Melton et al., 2010) and cell cycle regulators
critical for the ES cell phenotype (such as CDK6,
CDC25A, and cyclin D) (reviewed in (Mallanna and Riz-
zino, 2010). Expression of let-7 miRs can promote differen-
tiation of pluripotent stem cells, and a let-7 inhibitor
promotes dedifferentiation; thus, let-7 downregulation is
likely essential to reprogramming (Melton et al., 2010).
Let-7 inhibition stimulates OSK reprogramming efﬁciency
(without c-MYC) to the same extent as does c-MYC, and
forced let-7 expression decreases reprogramming efﬁ-
ciency (Worringer et al., 2014). Moreover, a connection be-
tween EMT factors and the transcriptional regulation of
let-7 has been reported (Chang et al., 2011; Kong et al.,
2010; Li et al., 2009).
Here we set out to evaluate the roles of transcriptional
regulators associated with EMT in iPSC reprogramming.
We were intrigued by data from published reports that
EMT factors (including SNAI1) increased during the early
stages of reprogramming (Mikkelsen et al., 2008; Sama-
varchi-Tehrani et al., 2010). We were likewise perplexed
by the continued expression of this and other EMT factors
at time points when genes downregulated by them were
strongly expressed. Thus, we examined the roles of SNAI1
during reprogramming.
RESULTS
Effects of SNAI1 on Reprogramming
We investigated expression levels of SNAI1 and pluripo-
tency markers POU5F1 (OCT4) and LIN28A during OSKM
reprogramming (Figures S1A and S1B available online) of
ﬁbroblasts and keratinocytes and found that SNAI1 expres-
sion was variably increased through intermediate stages in
reprogramming in both mouse and human cultures. Our
expression data were consistent with published microar-
rays showing, in ﬁbroblasts, upregulation of SNAI1 and
other EMT factors early in mouse reprogramming, while
reduced SNAI1 levels were not observed until day 8 (Mik-
kelsen et al., 2008; Samavarchi-Tehrani et al., 2010).
Although the kinetics of reprogramming are variable be-
tween experiments, we consistently observed early upregu-
lation of SNAI1, leading us to hypothesize that it might
play a positive role.
To explore the role of SNAI1, we knocked it down in mu-
rine ﬁbroblasts and evaluated the effects on the efﬁciency
of reprogramming. We conﬁrmed that SNAI1 was knocked
down by quantitative PCR (qPCR) and immunoblot (Fig-
ures S1C and S1D). Unexpectedly, we observed that knock-
down (KD) caused a trend toward decreased rather than
increasedreprogrammingefﬁciencyintwodifferentmouse
strains, C57BL/6 3 129 (B63129) and mouse strain Friend
Virus B (FVB) (Figures 1A and 1B). To enable analysis of live
colonies, we used colony morphology and stage-speciﬁc
embryonic antigen 1 (SSEA-1) expression as our indicator
of successful reprogramming, after showing that numbers
based on Nanog expression in ﬁxed colonies correlated
with those obtained by SSEA-1 labeling (Figure S1E). To
investigate whether EMT factors play similar roles in re-
programming of human somatic cells, we employed a ‘‘sec-
ondary’’ reprogramming system in which ﬁbroblasts were
differentiated from iPSCs carrying doxycycline (dox)-
inducible reprogramming factors (Figure S2A) (Kim et al.,
2011). In secondary human ﬁbroblasts (D2F), KD of
SNAI1 likewise compromised reprogramming (Figures 1A,
1B, and S1C).
We then enforced expression of SNAI1 by tamoxifen
(TMX) induction of an estrogen receptor (ER) fusion
construct prior to the initiation of reprogramming (Mani
et al., 2008). In ﬁbroblasts, levels of expression of EMT
factors are relatively low, and they increase upon TGF-b
treatment (Figure S2B). While constitutive SNAI1 overex-
pression during reprogramming has been shown to
decrease efﬁciency (Li et al., 2010), its effects during the
early timeframe have not been tested. We monitored rates
of proliferation since SNAI1 is known to play a role in cell
cycle regulation (Vega et al., 2004). Upon TMX addition
to control versus SNAI1-expressing cells, changes in prolif-
eration rates were not signiﬁcant (Figure S2C). SNAI1
expression in the nucleus increased upon TMX treatment
(Figures 2A and S2D). Cells in which SNAI1 had been
induced were then reprogrammed by viral transduction
following cessation of TMX. In MEFs from FVB mice, over-
expression of SNAI1 prior to reprogramming increased
efﬁciency, while in B63129, a strain with high baseline re-
programming efﬁciency, SNAI1 did not further augment
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the two strains was similar (Figure S2I).
We reasoned that if SNAI1 plays a role in reprogramming
we should observe a more dramatic effect on the reprog-
ramming of epithelial cells, such as keratinocytes, because
their intrinsic level of expression of SNAI1, although not
absent, is lower than in ﬁbroblasts (Figure S2F). To test
this and to discern the effect in human cells, we overex-
pressed SNAI1 via ER fusion in human ﬁbroblasts and
keratinocytes prior to reprogramming and conﬁrmed
TMX-induced nuclear translocation (Figure S2E). Overex-
pression of SNAI1 in both cell types caused an enhance-
ment of colony formation, with a more pronounced effect
in epithelial cells (Figure 2C), conﬁrming that both mesen-
chymal and epithelial cell types reprogram more efﬁciently
when SNAI1 is expressed. Accordingly, with respect to
ﬁbroblasts, SNAI1 expression is more markedly upregu-
lated in keratinocytes, presumably due to lower starting
levels (Figures S1A and S1B).
Cells Expressing Endogenous SNAI1 Reprogram More
Efﬁciently
Before reprogramming, MEFs expressed low levels of SNAI1
(Figure 3A, upper panel). Early in the reprogramming
process (days 1–7), endogenous SNAI1 became localized
to the nucleus (Figure 3A, lower panel; day 5 shown;
Figure S3D).
To test whether cells expressing endogenous SNAI1 are
more efﬁciently reprogrammed, we isolated cells from
mice with a knockin reporter construct that enables selec-
tion for cells expressing SNAI1 by virtue of yellow ﬂuores-
centproteincoexpressionfromaninternalribosomalentry
site (T.S. and R.A.W., unpublished data). We noted varying
proportions of YFP-positive cells in tail tip ﬁbroblasts and
mouse embryonic ﬁbroblasts (MEFs). Sorted SNAI1-YFP-
positive and -negative populations expressed higher and
lower levels of SNAI1 mRNA, respectively (Figure S3A).
YFP-positive fractions showed an increased reprogram-
ming efﬁciency for SNAI1 (6.53) as compared with nega-
tive populations (Figure 3B). We found that upon culture
fewer YFP-negative than YFP-positive cells resulted, either
because of proliferative or cell death differences, but after
normalizing for cell number differences (as described in
Experimental Procedures), enhancement was still seen for
SNAI1 (2.63, Figure 3C).
We observed an increase in SNAI1 expression early in re-
programming in B63129, but not in FVB (Figure S3B), the
strain in which SNAI1 overexpression increased efﬁciency.
SNAI1 expression was also seen in mouse peripheral blood
reprogramming (Figure S3C). Thus, an increase in SNAI1
expression was seen across mesenchymal, epithelial, and
peripheral blood cell types and could be observed by moni-
toring RNA or protein.
SNAI1 Expression Is Temporally Associated with Let-7
Downregulation
Next, we explored the potential mechanism by which
SNAI1 enhances reprogramming, noting the references
that link EMT with downregulation of the let-7 family of
tumor suppressor miRs (Chang et al., 2011; Kong et al.,
2010; Li et al., 2009; Yang et al., 2012). Using inducible
Snail ER, we observed downregulation of let-7 after 7 days
of TMX treatment in mouse ﬁbroblasts (Figures 4A and
S4A). KD of SNAI1 resulted in increased let-7 expres-
sion (Figure 4B). Chromatin immunoprecipitation (ChIP)
conﬁrmed that SNAI1 binds the promoters of several let-7
family members during early stages of reprogramming in
B63129 ﬁbroblasts (Figure 4C) and in FVB overexpressing
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Figure 1. KD of SNAI1 in Fibroblasts Decreases Reprogramming
Efﬁciency
(A) In MEFs or D2F, SNAI1 was knocked down by three different
shRNAs individually, followed by retroviral reprogramming or dox
addition, and colonies were counted based on morphology and
SSEA-1 or Tra1-60 labeling after 21 or 28 days, respectively,
normalized to cell number on day 3. Shown is fold change relative
to control (scrambled shRNA); bars indicate shControl (white) and
shSNAI1 (black). n = 10–22 in four to nine biological replicates.
Error bars show SEM. *p < 0.05. B63129: p = 0.06, FVB: p = 0.08.
See also Figure S1.
(B) SSEA-1 labeling of B63129 (left), FVB (middle), or Tra1-60
labeling of D2F (right); control shRNA (upper) and SNAI1 KD
(lower) are shown.
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SNAI1 Enhances ReprogrammingSNAI1-ER more so than without induction (Figure S4B).
Upon TMX treatment of SNAI1-ER expressing ﬁbroblasts
(withoutreprogramming),SNAI1bindingtolet-7members
similarly increases (Figure 4D).
We evaluated expression of let-7 during OSKM-induced
reprogramming and found let-7a, let-7e, let-7g, and let-7i
decreased in both ﬁbroblasts and keratinocytes in the early
phase (Figures 4E, 4F, S4C (parallel ﬁbroblast data for Figure
S1A), and S4D). A similar trend can be seen in the case of
mouse peripheral blood (Figure S4E). To understand the
role of let-7 in reprogramming, we expressed let-7 in
MEFs from a strain of mice carrying a dox-inducible trans-
gene at various stages of reprogramming (Zhu et al., 2011).
We found that let-7 overexpression compromised efﬁ-
ciency when done during the ﬁrst, but not the second,
7daysofreprogramming(Figure4G).Wealsonotedatrend
toward higher expression of several let-7 members in FVB
than in B63129 strain prior to reprogramming, correlating
highexpressionwithaugmentationofreprogrammingefﬁ-
ciency upon SNAI1 overexpression (Figure S4F). These data
suggest downregulation of the let-7 miRs as a possible
mechanism by which SNAI1 inﬂuences reprogramming
(diagrammed in Figures 4H, S4G, and S4H).
DISCUSSION
Fibroblasts are the typical starting population for somatic
cell reprogramming, and prior studies have indicated that
reprogramming involves an MET. Paradoxically, however,
transcription factors associated with EMT are expressed
early in the reprogramming process and are not downregu-
lated until the later stages (Samavarchi-Tehrani et al.,
2010). While previously it was reported that keratinocytes
could be reprogrammed with higher efﬁciency because of
their pre-existing epithelial status (Maherali et al., 2008),
a side-by-side comparison between cell types has not
been done. In a secondary reprogramming system that en-
ables direct comparison, we found mouse keratinocytes
were reprogrammed less efﬁciently (0.02%) than ﬁbro-
blasts (0.3%) (Figure S3E), and we have discovered ectopic
expression of the EMT factor SNAI1 during early stages of
reprogramming enhances efﬁciency in keratinocytes, an
epithelial cell type. Thus, the effect of expression of EMT
factors in the initial phase of reprogramming is not limited
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Figure 2. Overexpression of SNAI1 via ER Fusion Improves
Reprogramming Efﬁciency
(A) A B63129 line expressing SNAI1-ER was created by retro-
viral transduction. Cells were treated with TMX for 12 days and
ﬁxed and labeled. With (lower) or without induction (upper);
SNAI1 labeling, green; DAPI, blue; 403, scale bar represents
50 mm.
(B) Mouse ﬁbroblasts of indicated strain were reprogrammed and ef-
ﬁciencycalculated based oncolonymorphologyandSSEA-1 labeling.
(C) D2F or D2K were reprogrammed as in B and Tra 1-60+ colonies
labeled. (B and C) White bars, SNAI1-ER; black, empty vector; fold
increase over no TMX is shown. n = 3–14, 2–6 biological replicates.
Error bars in (B) and (C) show SEM. *p < 0.05.
See also Figure S2.
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SNAI1 Enhances Reprogrammingto mesenchymal target cell populations, but also occurs in
epithelial cells, suggesting mesenchymal factor expression
is an important aspect of reprogramming independent of
startingcelltype.ManipulatingSNAI1hasledustoamulti-
step model of reprogramming whereby mesenchymal
factorsareexpressedearlyandcontributetothereprogram-
ming-amenable state (Koche et al., 2011), and only there-
after are pluripotency factors expressed en route to the
pluripotent state seen in iPSCs (Figure 4H). Our data are
in agreement with a recent study (Liu et al., 2013), which
reported early enhancement of the mesenchymal state
increased reprogramming efﬁciency.
A role for let-7 in reprogramming has been established
since its inhibition increases reprogramming efﬁciency
(Melton et al., 2010). As shown here, SNAI1 binds several
let-7 promoters, and SNAI1 expression is associated tempo-
rally with downregulation of let-7 miRs early in reprogram-
ming, consistent with prior evidence that EMT factors
suppress let-7 expression in cancer (Yang et al., 2012).
Moreover, overexpressing SNAI1 in a poorly reprogram-
ming strain augments both reprogramming efﬁciency
and SNAI1 binding to the let-7 promoter, suggesting
SNAI1 regulation of let-7 may be the basis for enhanced re-
programming efﬁciency. The downregulation of let-7 tran-
scription by SNAI1 may be associated with upregulation of
LIN28 by pluripotency factors, thereby potently reversing
the differentiated state. While let-7 is downregulated in
the ﬁrst week of reprogramming, its expression appears to
recover thereafter before again diminishing to near zero
in the iPSC state (Figures 4E, 4F, and S4D). We have not
studied this biphasic expression pattern, but we hypothe-
size the second wave is extinguished by LIN28.
Prior studies have demonstrated that Twist promotes a
stem cell phenotype in cancer, including self-renewal
(Mani et al., 2008). We hypothesize that expression of
SNAI1 might similarly promote a stem cell-like phenotype
in ﬁbroblasts and keratinocytes, moving them one step
closer to dedifferentiation and making them more
amenable to reprogramming. We propose that suppression
of let-7 miRs is a mechanism whereby SNAI1 might be
acting to confer these stem cell properties.
Building on the model proposed by Samavarchi-Tehrani
et al. and Li et al. demonstrating the role of MET in reprog-
ramming, we show during the early phases of reprogram-
ming, mesenchymal factors are expressed, and further
ectopic expression of EMT factors enhances reprogram-
ming efﬁciency. Our results provide a more nuanced view
of the role of EMT factors in the reprogramming of both
mesenchymalandepithelialcelltypes.Ourdataarecorrob-
orated by an independent study that identiﬁed SNAI1 in an
unbiased shRNA screen as a factor that enhances conver-
sion of pre-iPS cells to a fully reprogrammed state, thereby
reinforcing the conclusion that SNAI1 acts to enhance re-
programming (Gingold et al., 2014). This improved under-
standing of the mechanism of reprogramming will provide
strategies to improve its utility for modeling and treating
disease and advance our insight into the regulation of
gene expression and pluripotency.
EXPERIMENTAL PROCEDURES
Mice and Cells
AllmousestudieswereapprovedbytheBostonChildren’sHospital
IACUC and were done in accordance with institutional and
national standards and regulations. Mouse keratinocytes were iso-
latedfromneonatal mice,culturedinCnT-07medium(Cell-N-Tec,
ZenBio) and reprogrammed at ﬁrst passage. Second-generation
inducible iPSCs were generated from H1 human embryonic stem
cellbydifferentiationtoﬁbroblasts(Parketal.,2008),transduction
with inducible OSKM lentiviruses (Stadtfeld et al., 2008), and dox
AB
C
Figure 3. SNAI1 Expression, Upregulated
Early in Reprogramming, Predicts Higher
Reprogramming Efﬁciency
(A) On days 0 and 5 of reprogramming, B63
129 ﬁbroblasts were labeled with anti-
SNAI1 (green, left panels) and DAPI (blue,
overlaid with green in right panels); 403,
scale bar represents 50 mm.
(B) YFP-positive and -negative sorted MEFs
from SNAI1-YFP knockin mice were retro-
virally reprogrammed. SSEA1+ colonies were
counted on day 21; representative images
are shown.
(C) Quantiﬁcation of colonies, normalized
for cell number on day 3. n = 7–19, 5 bio-
logical replicates. Error bars show SEM.
See also Figure S3.
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Figure 4. Snail Expression Is Temporally Associated with Downregulation of Let-7
(A) qPCR analyses on let-7 expression upon SNAI1 overexpression. After 7 or 10 days of TMX treatment, B63129 ﬁbroblasts stably
expressing SNAI1-ER were tested for levels of expression of let-7 revealed by TaqMan qPCR (n = 3–4 biological replicates). Error bars
show SEM.
(B) qPCR analyses of let-7 expression upon SNAI1 KD. B63129 ﬁbroblasts with lentiviral SNAI1 KD were analyzed for expression of let-7
(n = 3 biological replicates). Error bars show SEM.
(legend continued on next page)
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SNAI1 Enhances Reprogramminginduction. Keratinocytes were differentiated from iPSCs by a 6 day
culture in basic ﬁbroblast growth factor-free media followed
by dissociation and 3–4 day culture in keratinocyte serum-free
medium (Invitrogen) +/  retronectin (Takara Shuzo) (Kim et al.,
2011).
Reprogramming
Retroviral-mediated mouse reprogramming was via pmX con-
structs. Second-generation inducible ﬁbroblasts or keratinocytes
were induced by addition of dox at 2 mg/ml 12–24 h after
plating. In both cases, cells were replated onto irradiated MEFs
(GlobalStem) 3 days (mouse) or 5 days (human) after expression
of the four factors, with daily changes of mouse or human ES cell
media thereafter.
Flow Cytometry
Tail tip ﬁbroblasts or MEFs positive or negative for YFP were sorted
on a FACSAria (BD). Cells were used immediately for reprogram-
ming or qPCR.
ChIP Assays
ChIP analyses were carried out as described (Cesana et al., 2011).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four ﬁgures, and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.09.008.
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